By Elinor Zuke2025-06-25T07:06:00
Kantar’s latest figures have been picked up by several papers, with the majority of headlines focused on rising inflation and the potential impact of GLP-1 weight-loss drugs on falling volumes
Kantar’s latest figures have been picked up by several papers, with the majority of headlines focused on rising inflation and the potential impact of GLP-1 weight-loss drugs on falling volumes.
Already have an account? Sign in here
Already have an account? Sign in here
You’ve used up your article allowance